Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism

BACKGROUND: We examine the clinical significance and biomarkers of tissue plasminogen activator (tPA)-catalyzed clot lysis time (CLT) in patients with intermediate-risk pulmonary embolism (PE). METHODS: Platelet-poor, citrated plasma was obtained from patients with PE. Healthy age- and sex-matched p...

Descripción completa

Detalles Bibliográficos
Autores principales: Stubblefield, William B., Alves, Nathan J., Rondina, Matthew T., Kline, Jeffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751085/
https://www.ncbi.nlm.nih.gov/pubmed/26866684
http://dx.doi.org/10.1371/journal.pone.0148747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751085/
https://www.ncbi.nlm.nih.gov/pubmed/26866684
http://dx.doi.org/10.1371/journal.pone.0148747

Ejemplares similares